Individual Early Warning Score (I-EWS)

November 1, 2019 updated by: Kasper Iversen, Herlev Hospital

Individual Early Warning Score (I-EWS) - Does Clinical Assessment Improve Detection of Acute Deterioration in Hospitalized Patients - a Cluster-randomized Trial

Early Warning Score (EWS) is a clinical scoring system used in hospitals in Denmark and internationally to systematically observe admitted patients using a standardised response algorithm. Consisting of a score based on the patients' vital signs, it only leaves limited space for individual assessment. Patient safety but also resource utilisation is a key issue in health systems today. We have developed a new individual EWS system (I-EWS) that reintroduces the individual clinical assessment for a more personalised observation. Our hypothesis is that I-EWS will not increase the mortality among hospitalised patients compared to EWS but will improve workflow by reducing unnecessary observations and freeing staff resources, potentially leading to improved patient care. The impact of I-EWS on mortality, the occurrence of critical illness, and usage of staff resources will be evaluated in a prospective, cluster randomised, non-inferiority study conducted at eight hospitals in Denmark.

Study Overview

Detailed Description

Every year more than 250,000 patients are admitted in the Capital Region of Denmark. During admissions, the clinical track and trigger system "Early Warning Score" (EWS) is used to systematically observe and detect acutely deteriorating patients. The system is designed to prevent serious adverse events like unanticipated transfer to the intensive care unit, cardiac arrest and unexpected death. EWS consists of standardized measurements of the patient's vital signs and an escalation protocol that determines further actions based on the aggregated EWS score. At admission, and as a minimum twice a day, nurses measure vital signs on all hospitalized patients. Depending on the predetermined cut-off values (i.e. heart rate above 150 bpm = 3 points) an aggregated score is calculated. Based on the total score, the escalation protocol determines the time interval for the next measurement as well as a clinical action (i.e. call for attending doctor). EWS is developed to detect and to treat potentially deterioration of disease that might lead to critical illness and death. In its current form, there is only limited room for individual clinical assessment.

A standardized track and trigger system like EWS does not differentiate between different types of disease or the patient's individual physiological response. Therefore, there is a potential risk that the system fails to detect a patient with an abnormal stress response. Additionally; patients suffering from chronic illness might have different normal values than healthy patients, leading to unnecessarily excess observation, measurement, and suboptimal usage of limited staff resources.

Previous studies have shown that Early Warning System scores perform well for prediction of cardiac arrest and death within 48 hours, although the impact on health outcomes and resource utilization remains uncertain, often owing to methological limitations.

It is possible, but never studied before, whether the combination of vital signs with individual clinical assessment is a better tool for identifying hospitalized high-risk patients than the existing algorithms.

Further improvement and optimizing of the EWS is necessary, as there is potential to improve patient care and use staff resources more appropriate.

The purpose of the study is to investigate the impact of the I-EWS that has a systematic involvement of clinical assessment and the possibility to adjust the score, whilst keeping the same escalation protocol. I-EWS will be compared to the existing EWS with a focus on mortality, critical illness, and the use of staff resources.

Our hypothesis is that I-EWS, where clinical assessment is given a more prominent role will not increase the mortality among hospitalized patients but can reallocate personnel resources.

I-EWS is built in to electronic patient journal system "Sundhedsplatformen" it is only available in Sundhedsplatformen (SP) at hospitals assigned to I-EWS. Four hospitals are randomized to use I-EWS for 6,5 months, the remaining four hospitals are control hospitals using the current EWS in this period.

After 6,5 months a single cross-over will be preformed, and the previous control hospitals will use I-EWS over the next 6,5 months and the previous intervention hospitals, will go back to the current EWS for this period.

EWS scores and subsequent actions are documented in real time in SP. The first two weeks and final four weeks of each period will be excluded due to a implementation period. Data regarding patients, interventions and serious adverse events during hospitalization (i.e., cardiac arrest, the request of MET or unexpected death) will be accessed through SP and the Danish Central Registries (The Danish National Patient Registry, the Civil Registration System, DanArrest). After extraction, all data will be depersonalization and stored at a secured network in accordance with the current guidelines for data management in the Capital Region of Denmark.

Study Type

Interventional

Enrollment (Actual)

150000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital Region Of Denmark
      • Copenhagen, Capital Region Of Denmark, Denmark, 2400
        • Bispebjerg Hospital
      • Copenhagen, Capital Region Of Denmark, Denmark, 2650
        • Amager & Hvidovre Hospital
      • Copenhagen, Capital Region Of Denmark, Denmark, 2730
        • Herlev & Gentofte Hospital
      • Glostrup, Capital Region Of Denmark, Denmark, 2600
        • Rigshospital, Glostrup, Medical Ward
      • Hillerød, Capital Region Of Denmark, Denmark, 3400
        • Nordsjaellands Hospital
    • Region Of Zealand
      • Holbæk, Region Of Zealand, Denmark, 4300
        • Holbaek Hospital
      • Roskilde, Region Of Zealand, Denmark, 4000
        • Zealand University Hospital (Roskilde & Køge)
      • Slagelse, Region Of Zealand, Denmark, 4200
        • Slagelse Sygehus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All patients ≥18 years of age admitted more than 24 hours to a ward at participating hospitals will be included.

Participating hospitals are

  • Herlev & Gentofte Hospital
  • Nordsjaellands Hospital
  • Bispebjerg Hospital
  • Rigshospitalet, Glostrup - Medical Ward
  • Amager & Hvidovre Hospital
  • Zealand University Hospital
  • Slagelse Hospital
  • Holbaek Hospital

Exclusion Criteria:

  • Wards not using standard EWS, paediatric, obstetric and intensive, due to they use special variations (Pediatric early warning score, Obstetric Early warning Score or continous monitoring).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Arm - standard EWS procedure
Standard use of the current implement Early Warning System, based on the principles of the National Early Warning Score and with a standard escalation protocol.
Standard EWS - Based on principles of National Early Warning Score (NEWS)
Active Comparator: Intervention Arm - I-EWS

Implementation of Individual Early Warning Score (I-EWS) with a systematic clinical assessment with a standard escalation protocol as intervention 7 parameters (Respiration rate, pulse, saturation, systolic blood pressure, consciousness, temperature, Oxygen) are registered , an aggregated score is generated. In the electronic patient journal (Sundhedsplatformen), the nursing staff is asked to reevaluate the aggregated score based on their clinical assessment of the patient. The aggregated score can be upgraded with up to 6 points and downgraded with up to 4.

This new I-EWS score interacts with the standard escalation protocol which defines the observation frequency and relevant clinical actions.

In relation to systematic measurement of vital parameters the nursing staff will perform an individual clinical assessment of the patient and adjust the I-EWS score accordingly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All Cause mortality at 30 days
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day
Time Frame: Assessed after one year, after completion of the study
Assessed after one year, after completion of the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay
Time Frame: 30 days
Calculated as days from date of index admission to date of discharge
30 days
All Cause mortality at 2 days
Time Frame: 2 days (48 hours) after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
2 days (48 hours) after index admission
All Cause mortality at 7 days
Time Frame: 7 days (168 hours) after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
7 days (168 hours) after index admission

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of changes in I-EWS scores that lead to an escalation or de-escalation in the escalation protocol
Time Frame: Assessed after one year, after completion of the study
Assessed after one year, after completion of the study
Comparison of changes in EWS score due to I-EWS modification (intervention group) and due to temporary or chronic acceptable values (control group)
Time Frame: Assessed after one year, after completion of the study
Assessed after one year, after completion of the study
The number of Cardiac arrests* during hospital stay, reported in numbers (%)
Time Frame: Assessed after one year, after completion of the study
*Definition - Presence of a clinical cardiac arrest (as defined in the resuscitation guidelines) in patients without a DNAR (Do Not Attempt Resuscitation) order. Registered in DANARREST.
Assessed after one year, after completion of the study
The number of Cardiac arrests* during hospital stay, reported in number per 10,000 ward days
Time Frame: Assessed after one year, after completion of the study
*Definition - Presence of a clinical cardiac arrest (as defined in the resuscitation guidelines) in patients without a DNAR (Do Not Attempt Resuscitation) order. Registered in DANARREST.
Assessed after one year, after completion of the study
Scores generating a call for Mobile Emergency team (MET) reported in absolute number (%)
Time Frame: Assessed after one year, after completion of the study
Assessed after one year, after completion of the study
Scores generating a call for Mobile Emergency team (MET) reported in absolute per 10,000 ward days
Time Frame: Assessed after one year, after completion of the study
Assessed after one year, after completion of the study
Scores generating a call for the attending doctor, reported in absolute number (%)
Time Frame: Assessed after one year, after completion of the study
Assessed after one year, after completion of the study
Scores generating a call for the attending doctor, reported per 10,000 ward days
Time Frame: Assessed after one year, after completion of the study
Assessed after one year, after completion of the study
All cause mortality - Subgroup analysis of patients admitted to Herlev-Gentofte Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients admitted to Nordsjaellands Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients admitted to Bispebjerg Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients admitted to Glostrup Hospital (Medical Ward)
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients admitted to Amager-Hvidovre Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients admitted to Zealand University Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients admitted to Slagelse Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients admitted to Holbaek Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients Age ≤ 39 years
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients Age 40 to 69 years
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients Age ≥ 70 years
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients diagnosed with cardiovascular disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients diagnosed with cancer disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients diagnosed with pulmonary disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients diagnosed with infectious disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients diagnosed with neurological disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
All cause mortality - Subgroup analysis of patients diagnosed with surgical condition
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Herlev-Gentofte Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Nordsjaellands Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Bispebjerg Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Amager-Hvidovre Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Zealand University Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Slagelse Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients admitted to Holbaek Hospital
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients Age ≤ 39 years
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients Age 40 to 69 years
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients Age ≥ 70 years
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with cancer
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with cardiovascular disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with pulmonary disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with infectious disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with neurological disease
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission
The number of NEWS/I-EWS scores per patient per day - Subgroup analysis of patients diagnosed with surgical condition
Time Frame: 30 days after index admission
Time frame starts at the beginning of the index admission, defined as first admission in the study period.
30 days after index admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Kasper Iversen, MD, DMSci, Department of Cardiology, Herlev Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2018

Primary Completion (Actual)

October 31, 2019

Study Completion (Actual)

October 31, 2019

Study Registration Dates

First Submitted

September 26, 2018

First Submitted That Met QC Criteria

September 27, 2018

First Posted (Actual)

October 1, 2018

Study Record Updates

Last Update Posted (Actual)

November 4, 2019

Last Update Submitted That Met QC Criteria

November 1, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Risk Stratification

Clinical Trials on Standard EWS - Control (Trigger Tool)

Subscribe